Ujin Pharma Ltd.
NSE & BSETBA
TBA
1 Shares
TBA
₹10
Financial Summary
| Particulars | FY 2024-25 |
|---|---|
| 16,288.27 | |
| 72.36 | |
| 16,360.63 | |
| 15,933.81 | |
| 180.59 | |
| 141.27 |
Subscription Details
IPO Timeline
IPO Offer Start
TBA
IPO Offer Ends
TBA
TBA
Promoters
Book Running Lead Managers
Promoter Shareholding
Pre-IPO
98.50%
Promoter stake
Offered to Public
1,91,51,400
shares
IPO Registrar
KFIN Technologies Ltd.
About the Company
We are engaged in the distribution and supply of a diversified portfolio of solvents, specialty chemicals, acids, monomers, pharmaceutical raw materials and nutraceuticals. With over two decades of operational experience in the chemical industry, we have developed sourcing relationships with domestic and international suppliers, enabling us to procure a broad range of chemical products and supply them to traders, distributors and customers operating across multiple end-use industries. Our products are supplied to customers operating in pharmaceutical, agrochemical, specialty chemical, petrochemical, industrial and automotive sectors, as well as paints and coatings, printing inks and packaging applications. Our sourcing capabilities, supported by our distribution network and experience in procurement, logistics coordination and supply chain management, enable us to efficiently procure and supply chemical products across domestic and international markets. We support our customers throughout their procurement process by assisting with purchase planning, consolidating demand, and leveraging our relationships with domestic and international suppliers. We negotiate key commercial terms, including pricing, product specifications, quantities, and delivery schedules, while also managing the end-to-end supply chain, encompassing storage, handling, and logistics support. This integrated approach enables us to provide reliable, timely and cost-effective supply solutions to our customers As per the D&B Report, during the last three Fiscals and the period ended December 31, 2025, our Company supplied an aggregate of approximately 8,52,765.25 MT of chemical products to 3,034 customers. Our operations are supported by a distribution infrastructure comprising various warehouses and storage facilities located across Bhiwandi, Maharashtra and Kandla, Gujarat and a sourcing network of 1,277 suppliers.
Ujin Pharma Ltd. Latest News
IPO FAQs
The for the Ujin Pharma Ltd. IPO is 1 shares, which is also the minimum order quantity — you have to apply for at least 1 shares, and in multiples of 1 beyond that.
KFIN Technologies Ltd. is the for the Ujin Pharma Ltd. IPO.
The registrar processes the , refunds and the credit of shares to your demat account, so allotment-status queries go to them.
Ujin Pharma Ltd. IPO shares are proposed to be listed on BSE and NSE.
Each Ujin Pharma Ltd. share has a of ₹10.
Face value is the nominal value recorded in the company's books and is separate from the issue price you pay.
held 98.50% of Ujin Pharma Ltd. before the IPO.
1,91,51,400 shares of Ujin Pharma Ltd. are being offered to the public in this issue.
SMC Capitals Ltd and Marwadi Chandarana Intermediaries Brokers Pvt Ltd. are the for the Ujin Pharma Ltd. IPO.
Pre-apply means placing your Ujin Pharma Ltd. application before the subscription window actually opens. The bid is held and forwarded to the exchange on the opening day, so you don't have to submit it in the rush of the first morning.
Applying early doesn't improve your chances — when an issue is oversubscribed, the for investors is decided by a lottery, not by who applied first. Your money is only blocked once the application reaches the exchange.
You can apply in the Ujin Pharma Ltd. IPO online using either UPI or ASBA as the payment method. ASBA applications are made through the net banking of a bank account that supports IPO applications — the bank blocks the amount in your account instead of debiting it. UPI applications are offered by brokers that don't provide banking services: you enter your UPI ID and then approve the mandate request in your UPI app.
Either route needs a demat account. You bid for at least one lot, at a price within the or at the cut-off price, and the money stays blocked in your bank account until the is finalised.
Your broker or bank confirms the bid once it has been submitted to the exchange, usually within a few minutes during the bidding window. A UPI application only goes live after you approve the mandate request — ignore it and the bid lapses, even though it looks placed.
You can check the Ujin Pharma Ltd. bid independently on the NSE or BSE IPO bid-verification page a day after applying. An ASBA application also shows up as a blocked amount in your bank statement.